We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
42 hedge funds and large institutions have $47.3M invested in Arcturus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
950% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 2
367% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 3
167% more capital invested
Capital invested by funds: $17.7M → $47.3M (+$29.6M)
83% more funds holding
Funds holding: 23 → 42 (+19)
18.01% more ownership
Funds ownership: 14.31% → 32.32% (+18%)
36% less call options, than puts
Call options by funds: $385K | Put options by funds: $604K
Holders
42
Holders Change
+19
Holders Change %
+82.61%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
14
Reduced
3
Closed
2
Calls
$385K
Puts
$604K
Net Calls
-$219K
Net Calls Change
-$453K
Top Buyers
| 1 |
DI
DFPG Investments
Sandy,
Utah
|
+$4.98M |
| 2 |
TC
TownSquare Capital
Provo,
Utah
|
+$4.88M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.32M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$2.92M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.85M |
Top Sellers
| 1 |
HCM
Highline Capital Management
New York
|
-$1.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$28K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$3.39K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$1.08K |